BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 18604720)

  • 1. Pulmonary marginal zone lymphoma: a single centre experience and review of the SEER database.
    Stefanovic A; Morgensztern D; Fong T; Lossos IS
    Leuk Lymphoma; 2008 Jul; 49(7):1311-20. PubMed ID: 18604720
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A retrospective international study on primary extranodal marginal zone lymphoma of the lung (BALT lymphoma) on behalf of International Extranodal Lymphoma Study Group (IELSG).
    Sammassimo S; Pruneri G; Andreola G; Montoro J; Steffanoni S; Nowakowski GS; Gandini S; Negri M; Habermann TM; Raderer M; Li ZM; Zinzani PL; Adam P; Zucca E; Martinelli G
    Hematol Oncol; 2016 Dec; 34(4):177-183. PubMed ID: 26152851
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pulmonary marginal zone B-cell lymphoma of MALT type--what is a prognostic factor and which is the optimal treatment, operation, or chemotherapy?: Consortium for Improving Survival of Lymphoma (CISL) study.
    Oh SY; Kim WS; Kim JS; Kim SJ; Kwon HC; Lee DH; Won JH; Hwang IG; Kim MK; Lee SI; Chae YS; Yang DH; Lee GW; Choi CW; Park J; Suh C; Kim HJ
    Ann Hematol; 2010 Jun; 89(6):563-8. PubMed ID: 20024551
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Primary cutaneous marginal zone B-cell lymphoma: response to treatment and disease-free survival in a series of 137 patients.
    Servitje O; Muniesa C; Benavente Y; Monsálvez V; Garcia-Muret MP; Gallardo F; Domingo-Domenech E; Lucas A; Climent F; Rodriguez-Peralto JL; Ortiz-Romero PL; Sandoval J; Pujol RM; Estrach MT
    J Am Acad Dermatol; 2013 Sep; 69(3):357-65. PubMed ID: 23796549
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extranodal marginal zone B-cell lymphoma of the lung: experience with fludarabine and mitoxantrone-containing regimens.
    Zinzani PL; Pellegrini C; Gandolfi L; Casadei B; Derenzini E; Broccoli A; Quirini F; Argnani L; Pileri S; Celli M; Fanti S; Poletti V; Stefoni V; Baccarani M
    Hematol Oncol; 2013 Dec; 31(4):183-8. PubMed ID: 23212941
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment outcomes in patients with extranodal marginal zone B-cell lymphoma of the lung.
    Lee H; Yang B; Nam B; Jeong BH; Shin S; Zo JI; Shim YM; Kwon OJ; Lee KS; Kim H
    J Thorac Cardiovasc Surg; 2017 Jul; 154(1):342-349. PubMed ID: 28457544
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bronchial-associated lymphoid tissue lymphoma: a clinical study of a rare disease.
    Ahmed S; Kussick SJ; Siddiqui AK; Bhuiya TA; Khan A; Sarewitz S; Steinberg H; Sison CP; Rai KR
    Eur J Cancer; 2004 Jun; 40(9):1320-6. PubMed ID: 15177490
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical manifestations of primary pulmonary extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue in Japanese population.
    Ogusa E; Tomita N; Ishii Y; Takasaki H; Hattori Y; Matsumoto C; Ishigatsubo Y
    Hematol Oncol; 2013 Mar; 31(1):18-21. PubMed ID: 22278757
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue of the Salivary Glands: A Multicenter, International Experience of 248 Patients (IELSG 41).
    Jackson AE; Mian M; Kalpadakis C; Pangalis GA; Stathis A; Porro E; Conconi A; Cortelazzo S; Gaidano G; Lopez Guillermo A; Johnson PW; Martelli M; Martinelli G; Thieblemont C; McPhail ED; Copie-Bergman C; Pileri SA; Jack A; Campo E; Mazzucchelli L; Ristow K; Habermann TM; Cavalli F; Nowakowski GS; Zucca E
    Oncologist; 2015 Oct; 20(10):1149-53. PubMed ID: 26268740
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic factors and nomogram for survival prediction in patients with primary pulmonary lymphoma: a SEER population-based study.
    Low SK; Zayan AH; Istanbuly O; Nguyen Tran MD; Ebied A; Mohamed Tawfik G; Huy NT
    Leuk Lymphoma; 2019 Dec; 60(14):3406-3416. PubMed ID: 31322026
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retrospective comparison of the effectiveness of various treatment modalities of extragastric MALT lymphoma: a single-center analysis.
    Wöhrer S; Kiesewetter B; Fischbach J; Müllauer L; Troch M; Lukas J; Mayerhoefer ME; Raderer M
    Ann Hematol; 2014 Aug; 93(8):1287-95. PubMed ID: 24633660
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-Term Outcomes of 107 Cases of Primary Thyroid Mucosa-Associated Lymphoid Tissue Lymphoma at a Single Medical Institution in Japan.
    Watanabe N; Narimatsu H; Noh JY; Iwaku K; Kunii Y; Suzuki N; Ohye H; Suzuki M; Matsumoto M; Yoshihara A; Kameyama K; Kobayashi K; Kami M; Sugino K; Ito K
    J Clin Endocrinol Metab; 2018 Feb; 103(2):732-739. PubMed ID: 29165612
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcome and prognostic factors in ocular adnexal lymphoma.
    Nola M; Lukenda A; Bollmann M; Kalauz M; Petrovecki M; Bollmann R
    Croat Med J; 2004 Jun; 45(3):328-32. PubMed ID: 15185428
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dual institution experience of nodal marginal zone lymphoma reveals excellent long-term outcomes in the rituximab era.
    Starr AG; Caimi PF; Fu P; Massoud MR; Meyerson H; Hsi ED; Mansur DB; Cherian S; Cooper BW; De Lima MJ; Lazarus HM; Gerson SL; Jagadeesh D; Smith MR; Dean RM; Pohlman BL; Hill BT; William BM
    Br J Haematol; 2016 Oct; 175(2):275-280. PubMed ID: 27443247
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Conjunctival Lymphoma--An International Multicenter Retrospective Study.
    Kirkegaard MM; Rasmussen PK; Coupland SE; Esmaeli B; Finger PT; Graue GF; Grossniklaus HE; Honavar SG; Khong JJ; McKelvie PA; Mulay K; Prause JU; Ralfkiaer E; Sjö LD; Toft PB; Vemuganti GK; Thuro BA; Curtin J; Heegaard S
    JAMA Ophthalmol; 2016 Apr; 134(4):406-14. PubMed ID: 26891973
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Marginal zone lymphoma of the colon: case series from a single center and SEER data review.
    Trabolsi A; Alderuccio JP; Florindez J; Rodriguez G; Saul E; Iyer SG; Chapman JR; Poveda J; Sussman DA; Lossos IS
    Leuk Lymphoma; 2022 May; 63(5):1160-1166. PubMed ID: 34927537
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dual institution experience of extranodal marginal zone lymphoma reveals excellent long-term outcomes.
    Starr AG; Caimi PF; Fu P; Massoud MR; Meyerson H; Hsi ED; Mansur DB; Cherian S; Singh AD; Cooper BW; De Lima MJ; Lazarus HM; Gerson SL; Jagadeesh D; Smith MR; Dean RM; Pohlman BL; Hill BT; William BM
    Br J Haematol; 2016 May; 173(3):404-12. PubMed ID: 26953041
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinicopathological features of histological transformation from extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue to diffuse large B-cell lymphoma: an analysis of 467 patients.
    Maeshima AM; Taniguchi H; Toyoda K; Yamauchi N; Makita S; Fukuhara S; Munakata W; Maruyama D; Kobayashi Y; Tobinai K
    Br J Haematol; 2016 Sep; 174(6):923-31. PubMed ID: 27460179
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Results of Upfront Therapy for Marginal Zone Lymphoma.
    Ortega JL; Cabanillas F; Rivera N; Tirado-Gomez M; Hallman D; Pardo WI; Bruno M
    Clin Lymphoma Myeloma Leuk; 2017 Dec; 17(12):879-883. PubMed ID: 29042174
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primary mucosa-associated lymphoid tissue lymphoma of the salivary glands: a multicenter Rare Cancer Network study.
    Anacak Y; Miller RC; Constantinou N; Mamusa AM; Epelbaum R; Li Y; Calduch AL; Kowalczyk A; Weber DC; Kadish SP; Bese N; Poortmans P; Kamer S; Ozsahin M
    Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):315-20. PubMed ID: 21075560
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.